Shopping Cart
Remove All
Your shopping cart is currently empty
Anti-LILRA5/CD85f/ILT11 Antibody (7X39)
😃Good
Catalog No. TMAY-02809
Alias LIR-9, LIR9, LILRB7, leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5, ILT-11, ILT11, CD85F, CD85
Anti-LILRA5/CD85f/ILT11 Antibody (7X39) is a Rabbit antibody targeting LILRA5/CD85f/ILT11. Anti-LILRA5/CD85f/ILT11 Antibody (7X39) can be used in ELISA.
Anti-LILRA5/CD85f/ILT11 Antibody (7X39)
Anti-LILRA5/CD85f/ILT11 Antibody (7X39)
😃Good
Catalog No. TMAY-02809Alias LIR-9, LIR9, LILRB7, leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5, ILT-11, ILT11, CD85F, CD85
Anti-LILRA5/CD85f/ILT11 Antibody (7X39) is a Rabbit antibody targeting LILRA5/CD85f/ILT11. Anti-LILRA5/CD85f/ILT11 Antibody (7X39) can be used in ELISA.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 100 μL | $268 | 7-10 days | 7-10 days |
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
| Description | Anti-LILRA5/CD85f/ILT11 Antibody (7X39) is a Rabbit antibody targeting LILRA5/CD85f/ILT11. Anti-LILRA5/CD85f/ILT11 Antibody (7X39) can be used in ELISA. |
| Synonyms | LIR-9, LIR9, LILRB7, leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5, ILT-11, ILT11, CD85F, CD85 |
| Ig Type | Rabbit IgG |
| Clone | 7X39 |
| Reactivity | Human |
| Specificity | Human ILT11/LILRA5/LIR-9 |
| Application | |
| Recommended Dose | ELISA: 1:5000-1:10000 |
| Antibody Type | Monoclonal |
| Host Species | Rabbit |
| Construction | This antibody was obtained from a rabbit immunized with purified, recombinant Human LILRA5 (rh LILRA5; TMPY-00414; NP_067073.1; Met1-Arg268). |
| Purification | Protein A |
| Appearance | Liquid |
| Formulation | 0.2 μm filtered solution in PBS |
| Research Background | LILRA5 is a member of the leukocyte immunoglobulin-like receptor (LIR) family. LILR are a family of receptors possessing extracellular immunoglobulin domains. They are also known as CD85, ILTs, and LIR, and can exert immunomodulatory effects on a wide range of immune cells. ILT-11 contains 2 Ig-like C2-type (immunoglobulin-like) domains. It can be detected n tissues of the hematopoietic system, including bone marrow, spleen, lymph node, and peripheral leukocytes. Crosslink of ILT-11 on the surface of monocytes has been shown to induce calcium flux and secretion of several proinflammatory cytokines, which suggests the roles of this protein in triggering innate immune responses. |
| Conjucates | Unconjugated |
| Immunogen | Recombinant Protein: Human LILRA5 Protein (TMPY-00414) |
| Antigen Species | Human |
| Biology Area | ITIM/ITAM Immunoreceptors and Related Molecules |
Stability & Storage
| Stability & Storage | Store at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free. |
| Transport | Shipping with blue ice. |
Calculator
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . 
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Anti-LILRA5/CD85f/ILT11 Antibody (7X39) | purchase Anti-LILRA5/CD85f/ILT11 Antibody (7X39) | Anti-LILRA5/CD85f/ILT11 Antibody (7X39) cost | order Anti-LILRA5/CD85f/ILT11 Antibody (7X39)
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.